ArticleScience translational medicine2012
Treg cells in cancer: a case of multiple personality disorder.
Article in Science translational medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 25 citations in OpenAlex.
- Converting "cold" to "hot": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells.Cancer communications (London, England) · 2024Review
- Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy.Immunologic research · 2021Review
- MicroRNA (miR) dysregulation duringOncotarget · 2020Article
- Cell Intrinsic Deregulated ß-Catenin Signaling Promotes Expansion of Bone Marrow Derived Connective Tissue Type Mast Cells, Systemic Inflammation, and Colon Cancer.Frontiers in immunology · 2019Article
- High CD8BMC cancer · 2018Article
- Targeting latency-associated peptide promotes antitumor immunity.Science immunology · 2017Article
- Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.Journal of gastrointestinal cancer · 2016Article
- Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer.Cancer immunology, immunotherapy : CII · 2015Article
- Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology.Nature communications · 2015Article
- β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.Science translational medicine · 2014Article
- Article
- Microenvironmental regulation of tumor progression and metastasis.Nature medicine · 2013Review
- The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer.Clinical immunology (Orlando, Fla.) · 2013Review
- The two faces of regulatory T cells in cancer.Oncoimmunology · 2013Article
- Tailoring gut immune responses with lipoteichoic acid-deficient Lactobacillus acidophilus.Frontiers in immunology · 2013Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foxp3(+) RORγt-expressing T cells expand in colorectal cancer and contribute to pathogenesis in a mouse model of polyposis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.